Bioconsortia Raises $15M Series B Round From Khosla Ventures And Otter Capital
4/7/2014 9:45:27 AM
DAVIS, Calif.--(BUSINESS WIRE)--BioConsortia, Inc., an agricultural biotechnology company that uses a proprietary method for the selection of beneficial microbial consortia for crop improvement, has raised an additional $15 million in Series B funding. Khosla Ventures and Otter Capital participated equally in the round. This fund-raising round, along with the recent appointment of Marcus Meadows-Smith as the CEO of BioConsortia, accelerates the company’s plans to commercialize the use of microbial consortia as seed treatments and soil additives.
Help employers find you! Check out all the jobs and post your resume.
comments powered by